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The bone material interface has been an area of intense study over many decades, where studies of
the healing process ranging from simple mineral deposition in vitro to actual healing in vivo have
given important clues to the importance of calcium minerals in the bone/implant interface. Here,
the authors use a combination of in vitro cell culture methods and in vivo implantation to study
how the role of the spontaneously formed hydroxyapatite layer on Ti-implants for the in vivo-heal-
ing into the bone tissue of rat tibia. Initial experiments were made in reduced systems by incubation
of TiO2 in cell culture medium and analysis by time of flight secondary ion mass spectrometry
(ToF-SIMS) and energy-dispersive x-ray spectroscopy followed by subsequent exposure of human
embryological stem cells analyzed by von Kossa staining and environmental scanning electron
microsopy. In vivo studies of the bone–material interface was analyzed by ToF-SIMS depth profil-
ing using both C60
þ ions as well as a gas cluster ion source beam, Ar1500
þ as sputter source. The
low ion yield of the Ar1500
þ for inorganics allowed the inorganic/organic interface of the implant to
be studied avoiding the erosion of the inorganic materials caused by the conventional C60
þ beam.
VC 2017 Author(s). All article content, except where otherwise noted, is licensed under a Creative
Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). https://
doi.org/10.1116/1.4993986
I. INTRODUCTION
The bone–material interface of metal implants can be
metaphorically described as an archaeological excavation
site, where studies can deliver important clues to the mecha-
nism of bone healing at material surfaces. Consequently, the
bone-titanium implant border has remained an object of con-
tinuous study during four decades.1–15 However, studies of
the established material/bone interface cannot give definite
answers to the time-dependence of the subprocesses of bone
formation. The only possible way to obtain this information
is to make time-lapse studies of bone healing at implants.
The simplest system for such studies is to follow the mineral
deposition onto titanium oxide from simulated body fluids,16
or to analyze the adsorption of proteins and cells from blood
onto titanium.17 More complex studies can be made by ana-
lyzing bone healing at implants after various time periods of
healing.13
Recently, we found that hydroxyapatite (HA) is formed
spontaneously during incubation of Ti-implants with cell
culture medium or blood.18 The apatite formed was low
crystalline carbonated hydroxyapatite as detected by x-ray
photoelectron spectroscopy after incubation with cell culture
medium [Dulbecco’s modified Eagle’s Medium (DMEM)]
or low CaCO3, as detected as CaO
þ by Time of flight sec-
ondary ion mass spectrometry (ToF-SIMS) after incubation
in whole blood, suggesting that blood decreased the rate of
HA-formation.18 The HA layer on titanium is generally
thought of as being formed by passive precipitation, but
recent data on recovered implants show that Ti-surface is
coated with Ca, indicating a binding between Ti and Ca as
an early event in the healing process.19
The aim of the present study was to elucidate the role of
the spontaneously formed HA layer on Ti-implants for the
in vivo-healing into the bone tissue of rat tibia. The bone–-
material interface was analyzed by depth profiling using
ToF-SIMS with both C60
þ ions as well as a gas cluster ion
source beam (GCIB) using Ar1500
þ. Experiments were also
made in a reduced systems, incubation of TiO2 in cell culture
medium, analyzed by ToF-SIMS and energy-dispersive x-
ray spectroscopy (EDX), and subsequent exposure of human
embryological stem cells (hESCs) analyzed by von Kossaa)Electronic mail: malmper@chalmers.se
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Commercial granules of TiO2 (>99.9% pure, product
204757, lot MKBH6783V, Sigma-Aldrich, Stockholm,
Sweden) were incubated in cell culture medium (DMEM,
Gibco, Grand Island, NY. Product No. 11995-065) at 37 C
in humidified atmosphere for 24 h, rinsed in saline and dis-
tilled water, and dry sterilized at 160 C for 2 h. The grain
size was determined to 2 lm by light microscopy of a water
suspension. Sterilized dental implants were used as received
from Elos Medical AB (Timmersdala, Sweden) and were
implanted into rats as described in Sec. II G.
B. Human mesenchymal stem cell culture
The human embryonic stem cell (hESC) lines used in this
study were SA167MFG-hESC and AS034.1MFG-hESC at
passage 12 and 44, respectively, derived and characterized in
a previous study.20 Cell culture was performed at the
Department of Clinical Chemistry and Transfusion Medicine,
Institute of Biomedicine, University of Gothenburg. Note that
the stem cells used adhere to plastic surfaces and can be cul-
tured in polystyrene dishes.
C. Expansion of hESCs
In this study hESCs were expanded and differentiated
toward the osteogenic lineage directly onto tissue culture plas-
tic without any supportive coating. In brief, cells were
expanded in conditioned hES medium as described earlier con-
taining 80% KnockOutTM DMEM (Gibco-BRL/Invitrogen,
Gaithersburg, MD), 20% KnockOut serum replacement
(Gibco-BRL/Invitrogen), 2mM L-glutamine (Gibco-BRL/
Invitrogen), 0.1mM b-mercaptoethanol (Gibco-BRL/
Invitrogen), and 1% nonessential amino acids (Gibco-BRL/
Invitrogen) on Primaria
VR
dishes (Falcon, surface modified
polystyrene nonpyrogenic; Becton Dickinson, Franklin
Lakes) and were incubated in a humidified atmosphere at
37 C and 5% CO2 (Heraeus BBD6220). The SA167MFG-
hESC and AS034.1MFG-hESC were passaged every
4–6 days, and the medium was changed every second day.
D. Exposure of stem cells to TiO2 preincubated with
DMEM
Undifferentiated hESCs were cultured on regular tissue
culture plastic without predifferentiation stages such as
embryoid body formation.
Cell exposure was performed by adding the HA-coated
TiO2 in concentrations of 5 or 0.5mg/ml into the culture
medium for 24 h.
E. Fixation and Von Kossa staining
Mineral production was studied using von Kossa staining
performed by washing the cells in phosphate-buffered saline
followed by fixation in glutaraldehyde solution (25% in H2O
Sigma-Aldrich diluted 1:10) for 2 h. A solution of AgNO3
(2% w/v: Sigma-Aldrich) was added, and the plates were
kept in dark for 10min. The plates were then rinsed three
times with distilled H2O before being exposed to bright light
for 15min. After washing with distilled H2O, samples were
quickly dehydrated adding 100% EtOH prior to microscopic
inspection for mineralization as described earlier.21 Cells,
fixed with glutaraldehyde and dehydrated in ethanol, were
also analyzed by ESEM under low vacuum conditions.
F. Cell viability
hESCs were seeded onto a 24 well plate at density of 10
000 cells/well. Cells were incubated in growth medium with
or without the presence of metal oxides for 24 h to allow for
attachment. The attached cells were considered viable and
floating cells nonviable.
G. Animal surgery
All animal work was approved by the Gothenburg animal
experiment ethical committee. The surgery was performed as
described in a previous study,22 shortly as follows. Male
Sprague Dawley rats 200 g (Charles River, Holland) were
used. The animals were anesthetized with Isofluran (Baxter
Medical CO, Kista, Sweden). A hole was drilled (d¼ 1mm)
in the tibial facies lateralis. Sterile dental Ti-implants (Elos
Medtech, Timmersdala, Sweden) were implanted intramedul-
lary. The surface chemistry was analyzed by EDX and found
to be C 5.6%, O 13.2%, and Ti 94.5%. The animals were
kept at the Experimental Biomedicine facility and were fed
commercial pellets and water ad libitum. The animals were
harvested after 24 or 72 h or 5weeks by separating the heart
from the main arteries, and the tibia bones were dissected.
Four animals (eight implants) were used for ToF-SIMS anal-
ysis, and four animals were used for the EDX analysis.
H. Environmental scanning electron microscopy
and EDX
The rat tibiae were immersed into absolute ethanol on dry
ice. The bone tissue was substituted with alcohol for one
week at 80 C, warmed to room temperature, and cut with a
diamond saw, using absolute ethanol as lubricating liquid and
rinsed carefully in absolute ethanol. The samples were left to
dry at room temperature. An FEI Quanta 200 FEG ESEM
operating at an accelerating voltage of 20 kV was used for
imaging and chemical analysis. All images were acquired in
the backscattered electron imaging mode at a pressure of
1 Torr in the low vacuum region in order to avoid charging
effects. Energy dispersive x-ray (EDX) data was recorded
using an Oxford EDX detector and spectra were evaluated
with the INCA software. Results were expressed as mass % of
all detected elements or atom % for calculation of Ca/P ratio.
I. ToF-SIMS
ToF-SIMS analysis was performed with a TOF.SIMS 5
instrument (ION-TOF GmbH, M€unster, Germany) using a
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Bi3
þ cluster ion gun as the primary ion source. Multiple
(n¼ 5) regions ranging from 100  100 to 500 500 lm
were analyzed using a pulsed primary ion beam (Bi3
þ,
0.34 pA at 25 keV) with a focus of approximately 2lm and a
mass resolution of M/DM¼ 5000 fwhm at m/z 500. All spec-
tra were acquired and processed with the SURFACE LAB soft-
ware (version 6.4, ION-TOF GmbH, M€unster, Germany),
and the ion intensities used for calculations were normalized
to the total ion dose of each measurement. Depth profile
analysis was performed using the pulsed Bi3
þ gun (0.4 pA)
while sputtering was carried out with a 10 keV C60
þ beam
with a current of 0.6 nA. The maximum ion dose density of
Bi3
þ was kept at 2 1011 ions cm2 and therefore below
that of the static limit, i.e., 1 1013 ions cm2, to make sure
that the experiment was ended before the primary ion beam
had considerably damaged the surface of the sample. The
ion dose for C60
þ ranged from 4  1014 to 6  1014 ions
cm2. Low energy electrons were used for charge compensa-
tion during analysis. Profiles were also obtained using an
argon gas cluster ion beam (GCIB) source, using 20 keV
Ar1500 ions at a current of 0.364 nA. The ion dose for Ar1500
ranged from 4  1014 to 7  1014 ions cm2.
III. RESULTS AND DISCUSSION
The chemical composition of the samples was analyzed by
EDX and ToF-SIMS before (data not shown) and after incuba-
tion in DMEM. The EDX data from the analysis of untreated
TiO2 showed (mass %): C 23.3, O 41, and Ti 35.1. After incu-
bation in DMEM (n¼ 3), the sample showed (mass %): Ti
64.486 8.80, Ca 0.636 0.19, P 0.266 0.15, O 29.796 9.77,
and C 3.836 0.57. The Ca/P ratio (at. %) was 1.8.
Characterization of the TiO2 samples, control and prein-
cubated in DMEM by ToF-SIMS, is shown in Fig. 1. The
control showed clear signals from Tiþ and TiOþ (range not
shown) but no HA related peaks as can be seen in Fig. 1(a).
ToF-SIMS was however able to detect several ion species
from HA such as Ca2PO4
þ,Ca3PO5
þ, and Ca5PO7 on the
DMEM incubated sample as indicated in the spectrum in
Fig. 1(b).
The HA-coated TiO2 powder was then added to hESC cul-
tures. The cells proliferated during their exposure to the TiO2
grains. The loss of adhering cells was less than 10% of the cell
layer surface. Images of the exposed cell cultures are shown in
Fig. 2. Figure 2(a) shows a low magnification ESEM image of
the cell layer and polystyrene surfaces without cells. On the
polystyrene surfaces, single TiO2 grains or small aggregates of
grains are seen. On the cell layer, the TiO2 grains have been
taken up by the cells, as judged by light microscopy and
excreted into extracellular areas between the cells. These
aggregates are shown at higher magnification in Fig. 2(b).
Figure 2(c) shows an untreated cell culture control. Figure 2(d)
shows von Kossa stain image of the cultured hESCs exposed
to DMEM-preincubated TiO2. The cell layer contains silver
precipitate indicating the presence of mineral. As shown by
Bonewald et al.,23 the von Kossa staining is not specific for
HA, but can also stain “dystrophic mineralization of unknown
chemical composition.” Since the added TiO2 grains are
coated with low levels of HA, they may be stained by the von
Kossa. The aggregated TiO2 particles shown in Figs. 2(a) and
2(b) are also seen by light microscopy [Fig. 2(e)]. The aggre-
gate pattern of TiO2 grains in this image may be compared to
the von Kossa stained culture [Fig. 2(d)]. From this experi-
ment, we conclude that the cells, apparently, add mineral to
the aggregates during the process of uptake and excretion.
Ti-implants were operated into rat tibia and allowed to
heal for 24–72 h. The tissue layer formed during the first
3 days of healing was analyzed with depth profiling ToF-
SIMS as shown in Figs. 3(a)–3(c). Figures 3(a) and 3(b)
show data generated by conventional C60þ sputtering and
Fig. 3(c) data generated by sputter using a gas cluster ion
source using Ar1500
þ. The C60þ based profiles show a simi-
lar behavior with an initial layer consisting of cells and
organic matter, represented by the phosphatidylcholine head-
group, C5H15PNO4
þ, stemming from phosphatidylcholine
and phosphatidylethanolamine molecules, followed by a HA
layer, represented by signals from P2OH
þ and Ca2PO4
þ.
The CaOþ signal, likely stemming from CaCO3, peaks at
approximately 0.8  1014 ions/cm2 and is detected immedi-
ately before the titanium signal. The signal eventually
decays before the Tiþ reaches its maximum. Very little dif-
ference can be found between the 48 and 72 h samples with
regards to the organic and HA layers while the CaO layer
FIG. 1. (a) ToF-SIMS spectrum of control TiO2 powder. No hydroxyapatite
related ions can be detected. Total fluence 1.9  1012. (b) ToF-SIMS spec-
trum of TiO2 powder incubated in media analyzed with Bi3




þ are indicated. Total flu-
ence was 1.18  1012.
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possible appears to be thicker for the 48 h implanted surface.
Depth profiling using argon GCIB produces a somewhat dif-
ferent result as seen in Fig. 3(c), where the argon is unable to
erode the CaO away fully and CaO reached maximum at 3
 1014 ions/cm2 but never fully sputters away as for C60þ.
The Ar1500
þ beam is clearly not as efficient as C60
þ in sput-
tering the inorganic CaO layer. Ar clusters are known to be
very efficient in sputter removing organic layers without any
damage, but sputter inorganic material very slowly or not at
all depending on cluster size and energy.24–26
The elemental composition of the cut bone was C 27.3; N
4.06; O 35.94; Mg 0.44; P 11.8; and Ca 22.94. The elemental
composition of the bone in contact with the implant was C
28.31; N 4.43; O 28.3; Mg 0.28; P 11.3; and Ca 26.75.
However, the Ca levels are higher than the corresponding
values of untreated bone.27 The implant related bone thus
seems to be identical to the compact cortical bone after
5weeks of healing and the compact bone is affected by the
healing in of the implant, which is in accord with previous
findings during healing of MgO into bone.27 The 2D mor-
phology of the implant-related bone shows an archipelague
structure of the bone, interdigitated with areas of bone
marrow.
The time period of bone healing, 48–72 h, used in the pre-
sent study was chosen based on previous results from studies
on the time dependence of bone healing at titanium
implants.13,28–30 Callus bone appears in the wound after
96 h, apparently originating and extending from the endos-
teum and periosteum. The presented results show that the
titanium implant is coated with a stratified layer containing
CaOþ on the titanium surface, HA in an intermediate stra-
tum, and phosphatidylcholine from cell membranes were
found in an outer stratum, as seen in Fig. 3. This layering has
been confirmed by previous studies, showing crystals of HA
beneath the cells.5,8 The inner stratum of Ca on the Ti sur-
face has been described previously after analysis of the
bone-implant interface of healed-in implants by atom probe
tomography.19 This analytical method can only detect basic
elements and does not provide molecular information. The
result of the present study, made by analysis with ToF-SIMS,
suggests that the inner layer contains CaO, probably repre-
senting a Calcium mineral such as CaCO3 or Ca(HCO3)2
transformed to CaO by heat-generated sublimation of CO2 in
the ion beam. The formation of a CaO-layer on Ti-implants
after 1week of healing, as analyzed by ToF-SIMS, has been
reported previously.31 After this time of healing, the bone
FIG. 2. Human embryonic stem cells grown for 24 h with or without the presence of 0.5mg/ml of TiO2 grains, with a diameter of 2 lm, preincubated in
DMEM. After 24 h, the cells were fixed with 2.5% glutaraldehyde. (a) ESEM image of the surface of the culture dish showing cell-covered areas with large
aggregates of TiO2 grains and polystyrene areas with single grains or small clusters of TiO2 grains. Bar¼ 2mm. (b) ESEM image of the cell layer of cultured
hESCs with large aggregates of TiO2 grains in extracellular spaces, single grains or small clusters of TiO2 grains. Bar¼ 200lm. (c) ESEM image of the cell
layer of hESCs cultured in DMEM for 24 h and fixed in glutaraldehyde. Bar¼ 50lm. (d) Von Kossa staining of the cell layer of hESCs cultured in the pres-
ence of TiO2 grains. The Von Kossa-positive staining shows large aggregates of mineral in extracellular spaces. (e) Light microscopy of the cell layer of
hESCs cultured in the presence of TiO2 grains.
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marrow cavity is filled with callus bone and it is not certain
whether bone-mineral or Ca-mineral is detected. Also, the
ion gun used in the previous study did not allow for detection
of the HA-derived fragments32 as could be seen here, and
that are now routinely observed using cluster ion ToF-
SIMS.33
Here, we also see a clear difference in sputter ability
between the conventional C60
þ source and the GCIB argon
source. Even though the information about the different
layers are similar between the different sources, the argon
GCIB quickly erodes the organic material from the implant
while the inorganic CaO layer remains virtually unaffected
on the Ti surface as can be seen in Fig. 3(c). This is in con-
trast to C60þ that slowly erodes also the CaO layer from the
Ti surface. This is to be expected since GCIB sources are
well known or their high sputter yield for organic materials
compared with inorganic materials making them highly suit-
able for probing inorganic/organic implant surfaces.26,34
The results of several previous studies indicates the
existence of an organic stratum at the surface of a titanium
implant.3,5,8 This finding can still be a valid one and there is
no contradiction between the data presented here and previ-
ously published findings. As shown in Fig. 4, the titanium
surface is coated with approximately equally sized areas of
bone and bone marrow after 5weeks of healing. It is undis-
putable that a titanium surface in contact with blood is rap-
idly covered with plasma proteins and platelets,17 while the
CaO layer is formed at a lower rate,18 which means that it
forms by diffusion of Ca2þ through the pre-existing organic
layer. The results of a previous study indicates that the for-
mation of the HA-layer was slower in blood than in the cell
culture medium, whereas the CaCO3 layer was formed at
equal rates in both liquids, which can be explained by
inhibitory binding of osteopontin to the HA-layer.
Osteopontin is known to regulate the formation of HA,35 and
has been detected by immunocytochemistry at the bone-
implant interface.36 Osteopontin is not believed to affect the
differentiation of stem cells.37 Thus, it was important to per-
form the present study of the process of HA-coating of
Ti-implants in vivo. The presented data indicate that HA is
formed in vivo on top of a layer of CaCO3. This can be seen
in both the C60
þ as well as Argon1500
þ depth profiles where
HA is a clearly separated layer just below the organic
FIG. 3. (a) Depth profiling of an in vivo titanium implant after 48 h of healing using C60
þ. Depth profile analysis was performed using the pulsed Bi3
þ gun to
analyze an area of 156  156 lm while sputtering at 400  400 lm was carried out with a C60þ beam with a current of 0.6 nA. Ti is shown in blue, CaOþ in
orange, P2OH
þ in brown, Ca2PO4
þ in green, and C5H15PNO4
þ in red. Data are shown as normalized to maximum. Total fluence was 4  1014 ions/cm2 for
the C60
þ ions. (b) Depth profiling of an in vivo titanium implant after 72 h of healing using C60
þ. Depth profile analysis was performed using the pulsed Bi3
þ
gun to analyze an area of 216  216lm while sputtering at 300  300lm was carried out with a C60þ beam with a current of 0.6 nA. Ti is shown in blue,
CaOþ in orange, P2OH
þ in brown, Ca2PO4
þ in green, and C5H15PNO4
þ in red. Data are shown as normalized to maximum. Total fluence was 4.0  1014
ions/cm2 for the C60
þ ions. (c) Depth profiling of an in vivo titanium implant after 72 h days of healing using argon GCIB. Depth profile analysis was per-
formed using the pulsed Bi3þ gun to analyze an area of 70  70 lm while sputtering at 500  500lm was carried out with a Ar1500þ beam with a current of
1.3 nA. Tiþ is shown in blue, CaOþ in orange, P2OH
þ in brown, Ca2PO4
þ in green, and C5H15PNO4
þ in red. Data are shown as normalized to maximum.
Total fluence shown 1  1015 ions/cm2 for the argon ions.
FIG. 4. Ti-implant-related bone after 5weeks of healing. Compact bone, sur-
rounding the implant has been cut with a diamond saw. Bone in contact with
the implant (white areas) and soft tissue in contact with the implant (dark
areas) are shown.
041002-5 Malmberg et al.: Formation of HA on titanium implants 041002-5
Biointerphases, Vol. 12, No. 4, July/Aug 2017
components from cells and membranes, and CaOþ can be
seen tightly connected to the Ti implant itself. Hence the
implant is first coated by CaCO3, then phosphate before the
HA layer, which is then covered by cells and organic mate-
rial. The argon GCIB shows the most accurate result here
due to its low inorganic sputter yield hence allowing us to
probe the still intact inorganic CaO/Ti interface.
The production of HA by stem cells exposed to HA-
coated TiO2, as can be seen in Fig. 2, can be regarded as a
stress reaction and is not necessarily a sign of stem cell dif-
ferentiation, since differentiation of embryonic stem cells to
osteoblasts is expected to take 7 days rather than 24 h.38
However, stem cells can be a significant source of HA at the
bone-implant interface during bone healing, and HA itself
seems to promote the differentiation of stem cells.39
IV. SUMMARYAND CONCLUSIONS
We have demonstrated the advantage of using argon
GCIB for analyzing in vivo implants where now the organic/
inorganic interface can be probed much more accurately.
The results suggest that the established view of bone healing,
that bone progenitor cells react with the TiO2 surface, must
be reevaluated since the formation of hydroxyapatite on the
implant surface occurs more rapidly than the induction of
bone formation. The actual sequence of events is that
recruited stem cells are reacting to their contact with
hydroxyapatite at the Ti-surface. This insight is important
for a proper understanding of how implants heal into bone.
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